Structural Characteristics of Trunk and Limb Muscles in Cachectic Colorectal Cancer Patients
NCT ID: NCT06780423
Last Updated: 2025-09-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
60 participants
OBSERVATIONAL
2022-01-23
2025-09-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to determine the feasibility of taking muscle biopsies of cachectic colorectal cancer patients. Skeletal muscle characteristics will be compared between biopsies of the m. erector spinae and the m. vastus lateralis from cachectic colorectal cancer patients, non-cachectic colorectal cancer patients and healthy controls.
10 cachectic, 25 non-cachectic, and 25 healthy controls will be recruited for this study. It is an observational study, so measurements will be taken at one time point. Interventions/measurements:
* muscle biopsies
* blood samples
* 3D freehand ultrasound
* Short physical performance battery test
* handgrip strength
* questionnaires (activity pattern, quality of life)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Muscle Dysfunction in Gastrointestinal or Hepatobiliary Cancer
NCT03347162
Study of Microcirculatory Effects of Bevacizumab in Patients Treated for Metastatic Colon Cancer or Glioblastoma
NCT01810744
Liquid Biopsies and IMAging for Improved Cancer Care
NCT04224779
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
NCT06753136
Preoperative Sarcopenia and Surgical Outcomes in Colorectal Cancer Patients
NCT06698289
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cachectic colorectal cancer patients
Minimal invasive fine needle muscle biopsies
Fine needle muscle biopsies will be taken from the m. erector spinae and the m. vastus lateralis. Participants are placed in a standardized prone position on the examination table for measurements of the m. erector spinae and in a supine position for measurements of the m. vastus lateralis.
Non-cachectic colorectal cancer patients
Minimal invasive fine needle muscle biopsies
Fine needle muscle biopsies will be taken from the m. erector spinae and the m. vastus lateralis. Participants are placed in a standardized prone position on the examination table for measurements of the m. erector spinae and in a supine position for measurements of the m. vastus lateralis.
Healthy controls
Minimal invasive fine needle muscle biopsies
Fine needle muscle biopsies will be taken from the m. erector spinae and the m. vastus lateralis. Participants are placed in a standardized prone position on the examination table for measurements of the m. erector spinae and in a supine position for measurements of the m. vastus lateralis.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Minimal invasive fine needle muscle biopsies
Fine needle muscle biopsies will be taken from the m. erector spinae and the m. vastus lateralis. Participants are placed in a standardized prone position on the examination table for measurements of the m. erector spinae and in a supine position for measurements of the m. vastus lateralis.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* unwanted weight loss \> 5% in the last 6 months OR \> 2% unwanted weight loss in combination with a BMI \< 20kg/m2 OR \>2% unwanted weight loss in combination with sarcopenia
* Cachexia staging score (CSS): 5-12
* minimum age of 18 years old
* No unwanted weight loss \> 5% in the last 6 months OR \> 2% unwanted weight loss in combination with a BMI \< 20kg/m2 OR \>2% unwanted weight loss in combination with sarcopenia
* Cachexia staging score (CSS): 0-2
\- minimum age of 18 years old
Exclusion Criteria
* Insufficient knowledge of the Dutch language
* Muscle diseases affecting the spine and lower limbs
* Bedridden
Non-Cachectic cancer patients.
* Mental of psychological condition
* Insufficient knowledge of the Dutch language
* Muscle diseases affecting the spine and lower limbs
* Bedridden
Healthy controls.
* Mental of psychological condition
* Insufficient knowledge of the Dutch language
* Muscle diseases affecting the spine and lower limbs
* Bedridden
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hasselt University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
prof. dr. Kenneth Verboven
Prof. dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth Verboven, Professor
Role: PRINCIPAL_INVESTIGATOR
Hasselt University - REVAL
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hasselt University - REVAL research institution
Diepenbeek, Limburg, Belgium
Jessa Hospital
Hasselt, Limburg, Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/148 - CTLm-CCP
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.